Print Page  Close Window

Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2016 Annual Report on Form 10-K - PDF 2016 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$17.95
Change (%) Stock is Down 0.33 (1.81%)
Volume44,234
Data as of 02/20/18 10:22 a.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
02/08/18OraSure Technologies to Present at the LEERINK 7th Annual Global Healthcare Conference
BETHLEHEM, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the LEERINK 7th Annual Global Healthcare Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on February 14, 2018, at approximately 3:30 pm Eastern Time (12:30 pm Pa... 
Printer Friendly Version
02/07/18OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results
BETHLEHEM, Pa., Feb. 07, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the fourth quarter and full-year ended December 31, 2017. Financial Highlights Consolidated net revenues for the fourth quarter of 2017 were $52.0 million, a 47% increase from the fourth quarter of 2016. Consolidated net product revenues were $50.2 million, represent... 
Printer Friendly Version
02/02/18OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors
BETHLEHEM, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Dr. Aradhana Sarin, as a member of the Company's Board of Directors. Dr. Sarin will serve as a Class II Director with an initial term expiring at the Company’s 2020 Annual Meeting of Stockholders. She will also serve on the Audit Committee and Nominating and Corporate Governance Committee of th... 
Printer Friendly Version
01/17/18OraSure Technologies Earnings Conference Call Invitation
2017 Fourth Quarter Earnings Conference Call  Wednesday, February 7, 2018, 5:00 p.m. ET BETHLEHEM, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2017 fourth quarter financial results, 2018 first quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, February 7, 2018.  February 7, 2018 Schedule 4:00 p.m. ET 2017 fourth quarter financia... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/08/18 10:00 a.m. ET
OraSure Technologies, Inc. 2018 Annual Meeting of Stockholders
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources